Amplitude Surgical SA (EPA: AMPLI)

Market Cap	149.67M
Revenue (ttm)	106.02M
Net Income (ttm)	1.53M
Shares Out	47.97M
EPS (ttm)	0.03
PE Ratio	98.05
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Open	3.140
Previous Close	3.140
Day's Range	3.140 - 3.140
52-Week Range	2.700 - 3.580
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2024

About Amplitude Surgical

Amplitude Surgical SA designs, develops, and markets products for orthopedic surgery in France and internationally. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgery system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. The company ex...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 428
• Stock Exchange: Euronext Paris
• Ticker Symbol: AMPLI

Financial Performance

In 2024, Amplitude Surgical's revenue was 106.02 million, an increase of 5.81% compared to the previous year's 100.20 million. Earnings were 1.53 million, a decrease of -96.11%.